Revitalizing Health: Dialysis Industry Estimated to Become $145 Billion Market by 2030

As the world grapples with increasing healthcare needs and the prevalence of kidney-related issues, the dialysis market is poised for substantial growth, addressing the rising demand for efficient renal care.

According to the Next Move Strategy Consulting, the dialysis market is forecasted to witness significant expansion, reaching a market size exceeding its current $145 billion valuation by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 3.6% from 2022 to 2030.

Market Overview:

The dialysis industry is undergoing unprecedented growth, fueled by the escalating demand for advanced renal care solutions and the surge in healthcare transformation initiatives. With a focus on improving patient outcomes and enhancing the quality of life for those with kidney disorders, the dialysis market is expected to play a pivotal role in meeting the evolving healthcare needs globally.

Request a FREE sample report, here, https://www.nextmsc.com/dialysis-market/request-sample

Key Market Drivers:

1. Growing Incidence of Kidney Disorders: The increasing prevalence of kidney-related ailments is a primary driver propelling the Dialysis industry. As the global population ages and the incidence of conditions like chronic kidney disease rises, the demand for dialysis services is witnessing a significant uptick.

2. Advancements in Dialysis Technologies: Ongoing research and development initiatives in the field of dialysis technologies are yielding transformative results. Innovations in dialysis machines, materials, and processes are enhancing treatment efficiency, patient comfort, and overall effectiveness.

3. Rising Healthcare Awareness: The growing awareness about the importance of regular health check-ups and early detection of kidney disorders is driving increased demand for dialysis services. Patients are increasingly seeking timely and effective renal care, boosting the adoption of dialysis treatments.

4. Lifestyle Changes and Chronic Disease Epidemic: Changing lifestyles, including dietary habits and increased prevalence of conditions like diabetes and hypertension, contribute to the rise in chronic kidney diseases. The Dialysis market is addressing the healthcare challenges posed by these lifestyle factors.

5. Government Initiatives and Healthcare Investments: Governments worldwide are recognizing the burden of kidney diseases on healthcare systems and are taking steps to improve access to dialysis services. Strategic investments and healthcare reforms are creating a conducive environment for the growth of the Dialysis market.

Market Segmentation:

The dialysis market encompasses various segments, including:

Dialysis Type: Based on dialysis type, the market is segmented into hemodialysis and peritoneal dialysis.

Products & Services: Based on product & services, the market is classified into equipment, consumables, drugs, and services.

End User: Based on end user, the market is categorized into in-center dialysis and home dialysis.

Geographical Regions: Based on region, the market is analysed into North America, Europe, and Asia-Pacific, and Rest of the World (RoW).

For any queries, inquire before purchasing, here, https://www.nextmsc.com/dialysis-market/inquire-before-buying

Outlook and Future Prospects:

The Dialysis market is poised for sustained growth, driven by continuous technological advancements, increasing healthcare investments, and the rising prevalence of kidney disorders globally. The industry is expected to witness collaborations, research endeavors, and innovations that will further enhance the efficiency and accessibility of dialysis treatments.

Dialysis is a costly treatment, with average annual costs exceeding $90,000 per patient. These costs are primarily borne by healthcare systems and insurance providers, placing a significant burden on healthcare budgets. Thus, inhibiting the demand for the dialysis market.

Regional Dominance:

North America held the predominate share in the global dialysis market and is anticipated to sustain its dominance throughout the forecast period. This is primarily attributed to the rising prevalence of chronic kidney disease and end-stage renal disease, over one in seven adults in the U.S. are affected, as reported by the National Institute of Diabetes and Digestive and Kidney Diseases.

The U.S. dialysis market is anticipated to benefit from the increasing availability of reimbursement schemes and favorable government initiatives, supporting regional business expansion. For example, the Centers for Medicare & Medicaid Services (CMS) utilizes a prospective payment system (PPS), that reimburse dialysis expenses by offering a predetermined payment to dialysis service providers.

On the other hand, the Asia-Pacific region is experiencing significant expansion in the worldwide dialysis market, driven by the high prevalence of diabetes and hypertension, coupled with rising disposable incomes and a growing preference for technologically advanced products.

Access the full report, here, https://www.nextmsc.com/report/dialysis-market

Competitive Landscape:

The market comprises various players such as Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun, Avitum AG, and others. These market players are adopting various strategies such as acquisition and partnership to maintain their dominance in the global dialysis market.

For instance, in March 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, a company specializing in the preparation of dialysis concentrates. This acquisition seamlessly integrated Intermedt's product portfolio into B. Braun's comprehensive range of dialysis therapy solutions.

In addition, in May 2021, Davita Inc. integrated Baxter International Inc.'s HomeChoice Claria automated peritoneal dialysis (APD) equipment into its home dialysis program. This cutting-edge technology significantly enhanced the company's home dialysis offerings, representing a pivotal step towards promoting home-based dialysis as a preferred treatment option for patients.

Avail customized reports: https://www.nextmsc.com/services

Contact Us:

Next Move Strategy Consulting
Full Postal Address: 5th Floor, 867 BOYLSTON ST STE 500
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991 Website: www.nextmsc.com

About Us:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider committed to delivering high-quality market research reports. We assist multinational companies in gaining a competitive edge and expanding their industry presence by capturing a larger market share. Our research methodology combines primary research, secondary research, data mining, and data analytics to deliver reliable insights.

Over a decade, we have served over 1,000 global customers, including 90% of Fortune 500 companies. Our analysts constantly monitor high-growth markets and uncover hidden opportunities in various sectors. We offer top-quality syndicate and custom research reports across ten different industry verticals, catering to your unique business needs. Our industry-standard delivery solutions, from pre-consultation to after-sales services, ensure an exceptional client experience and support informed strategic decision-making.

This release was published on openPR.